These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5992627)

  • 21. [Urinary excretion of hydroxyproline in thyroid diseases].
    Siersbaek-Nielsen K; Skovsted L; Molholm Hansen J; Kristensen M; Korsgaard Christensen L
    Ugeskr Laeger; 1971 Mar; 133(11):491-3. PubMed ID: 5553235
    [No Abstract]   [Full Text] [Related]  

  • 22. A system for the estimation of the urinary hydroxyproline index.
    Howells GR; Whitehead RG
    J Med Lab Technol; 1967 Apr; 24(2):98-102. PubMed ID: 6042107
    [No Abstract]   [Full Text] [Related]  

  • 23. Urinary excretion of hydroxyproline in kwashiorkor.
    Anasuya A; Narasinga Rao BS
    Indian J Med Res; 1966 Sep; 54(9):849-57. PubMed ID: 5976564
    [No Abstract]   [Full Text] [Related]  

  • 24. [The behavior of hydroxyproline in urine in rheumatic children and their families].
    Vedovini F; Pieri J; Gorelli L
    Riv Clin Pediatr; 1966 Dec; 78(6):744-57. PubMed ID: 5999595
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radionuclide diagnosis of thyroid gland diseases in children].
    Zubovskii GA; Zamoskovnaia VA
    Vopr Okhr Materin Det; 1980 Jul; 25(7):7-11. PubMed ID: 7415031
    [No Abstract]   [Full Text] [Related]  

  • 26. The urinary 'hydroxyproline index' in hospitalised and normal Malaysian children.
    Chandrasekharan N; Candlish JK
    Trop Geogr Med; 1973 Mar; 25(1):71-4. PubMed ID: 4694000
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renal hydroxylysine glycoside excretion in children with ricketts-like diseases].
    Novikov PV; Shilov AV; Daĭkhin EI; Storozhev VL
    Vopr Okhr Materin Det; 1980 Sep; 25(9):53-7. PubMed ID: 7423894
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evolutional and clinical aspects of thyroid gland ectopia].
    De Medeiros-Neto GA; De Ulhõa Cintra AB
    Prensa Med Argent; 1966; 53(9):677-85. PubMed ID: 6004228
    [No Abstract]   [Full Text] [Related]  

  • 29. Thyroid disorders in children from birth to adolescence.
    Bettendorf M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S439-46. PubMed ID: 12192543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical treatment of thyroid diseases in children].
    Kononuchenko VP; Litovka VK; Sopov GA; Zhurilo IP; Poshekhonov AS
    Khirurgiia (Mosk); 1996; (4):50-2. PubMed ID: 8926669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of some biochemical indices to the assessment of physical development in children of different ages.
    Shamkhalova VG; Ananenko AA; Vel'mishchev YuE
    Hum Physiol; 1979; 5(2):165-9. PubMed ID: 544420
    [No Abstract]   [Full Text] [Related]  

  • 32. Epidemiological study on the hydroxyproline: creatinine ratio as an index of growth rate.
    Matsuki H; Kasuga H; Sugita M; Osaka F; Yokoyama H
    Tokai J Exp Clin Med; 1982 Mar; 7(2):271-8. PubMed ID: 7101331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosaminoglycan and hydroxyproline excretion in diabetic children.
    Klujber L; Szücs R; Baranyai Z; Gabulya J; Soltész Gy
    Acta Paediatr Acad Sci Hung; 1982; 23(1):27-34. PubMed ID: 6807050
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thyroid peroxidase antibodies and thyroid diseases in children and adolescents with newly diagnosed type I diabetes].
    Kalicka-Kasperczyk A; Dziatkowiak H; Bartnik-Mikuta A; Pituch-Noworolska A; Kasperczyk K; Nazim J; Sztefko K; Starzyk J
    Przegl Lek; 2002; 59(7):509-13. PubMed ID: 12516239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolism of hydroxyproline and hepatic hydroxyproline oxidase activity in infancy].
    Koizumi M
    Nihon Shonika Gakkai Zasshi; 1971 Mar; 75(3):207-14. PubMed ID: 5103714
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary hydroxyproline excretion in orthopedic disease, with special reference to systemic bone disease and bone tumor (secondary report).
    Nakagawa M; Sugiura Y; Oshima T; Kajino G; Hirako H
    Nagoya J Med Sci; 1967 Mar; 29(4):345-67. PubMed ID: 6066099
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of synthetic thyrotropin releasing hormone in children and adolescents with thyroid diseases].
    Hníková O; Kracmar P
    Cesk Pediatr; 1981 Sep; 36(9):545-7. PubMed ID: 6793247
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of surgical treatment of thyroid gland diseases in children].
    Sadykov FG; Enikeev RG; Nurmukhametova DS
    Khirurgiia (Mosk); 1994 Aug; (8):16-7. PubMed ID: 7990311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celiac disease in children with autoimmune thyroid disease.
    Larizza D; Calcaterra V; De Giacomo C; De Silvestri A; Asti M; Badulli C; Autelli M; Coslovich E; Martinetti M
    J Pediatr; 2001 Nov; 139(5):738-40. PubMed ID: 11713456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.